Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes

Por Pecorelli, S., Ray-Coquard, I., Tredan, O., Colombo, N., Parma, G., Tisi, G., Katsaròs, D., Lhommé, C., Lissoni, A. A., Vermorken, J. B., du Bois, A., Poveda, A., Frigerio, L., Barbieri, P., Carminati, P., Brienza, S., Guastalla, J. P.
Publicado em 2010

Novel antitenascin antibody with increased tumour localisation for Pretargeted Antibody-Guided RadioImmunoTherapy (PAGRIT(R))

Por De Santis, R, Anastasi, A M, D'Alessio, V, Pelliccia, A, Albertoni, C, Rosi, A, Leoni, B, Lindstedt, R, Petronzelli, F, Dani, M, Verdoliva, A, Ippolito, A, Campanile, N, Manfredi, V, Esposito, A, Cassani, G, Chinol, M, Paganelli, G, Carminati, P
Publicado em 2003